GSS Infotech Share Price: Q4 FY26 mein laga ₹49 Crore ka Loss, Polimeraas Investment ne kiya nuksaan

TECHNOLOGY
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
GSS Infotech Share Price: Q4 FY26 mein laga ₹49 Crore ka Loss, Polimeraas Investment ne kiya nuksaan
Overview

Arre yaar, GSS Infotech ka Q4 FY26 ka result aaya hai aur company ko **₹49.14 Crore** ka consolidated net loss hua hai. Iske peeche ka main reason hai Polimeraas Limited mein kiye gaye investment par **₹52.13 Crore** ka impairment loss. Aur toh aur, trading business ka revenue bhi kafi gir gaya hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more

GSS Infotech ka Q4 FY26 Results: Bada Loss?

Dekho bhai, GSS Infotech ne apna audited financial result announce kiya hai 31 March 2026 ko khatam hue fourth quarter aur poore saal ke liye. Sabse badi khabar ye hai ki company ko Q4 FY26 mein ₹49.14 Crore ka consolidated net loss hua hai. Ye loss badhne ka sabse bada reason ek exceptional item hai, jismein Polimeraas Limited mein kiye gaye investment par ₹52.13 Crore ka impairment loss record hua hai. Quarter ke liye consolidated revenue ₹28.16 Crore raha. Agar sirf standalone baat karein toh loss aur bhi zyada, matlab ₹52.57 Crore tha.

Ye Loss Important Kyu Hai?

Polimeraas Limited mein investment ka ye impairment loss ek one-time accounting entry hai jisne company ke reported profit ko kaafi affect kiya hai iss quarter aur poore financial year mein. Auditors ne toh opinion diya hai, par ye write-down seedha company ke net worth aur earnings per share par impact karta hai.

Iske alawa, company ke trading business mein revenue mein bhi zabardast kami aayi hai. Ye ya toh business ki strategy mein change ka sign ho sakta hai ya phir iss segment mein koi problem chal rahi hai.

Pichle Saal Kya Hua Tha?

Agar poore financial year 31 March 2026 ki baat karein, toh GSS Infotech ke software services segment ka revenue ₹87.12 Crore raha, jo pichle saal ke ₹99.38 Crore se kam hai. Trading business segment toh bohot hi neeche gir gaya, revenue ₹1.01 Crore raha jo pichle saal ₹25.79 Crore tha.

Ab Aage Kya?

Investors ko ab Polimeraas investment impairment ke long-term impact ko samajhna hoga. Halanki ye ek exceptional item hai, par ye subsidiary ki performance ya valuation mein issues ko highlight karta hai. Trading business revenue mein itni badi contraction bhi nazar rakhne wali baat hai ki ye temporary drop hai ya koi strategic change.

Kya Risks Hain?

Sabse bada risk ye hai ki agar subsidiaries ya associated companies ne underperform karna jari rakha toh aur impairment charges aa sakte hain. Trading business revenue mein itni girawat bhi risk hai agar ise doosre segments se recover nahi kiya gaya toh.

Context Metrics

Q4 FY26 mein consolidated revenue ₹28.16 Crore tha, jo Q4 FY25 ke ₹40.81 Crore se kam hai. Net loss Q4 FY25 ke ₹0.69 Crore se badhkar Q4 FY26 mein ₹49.14 Crore ho gaya hai.

Aage Kya Track Karein?

Investors ko management se investment impairment ke reasons aur trading business ke liye strategy janne ki koshish karni chahiye. Aage ke quarterly results se pata chalega ki company profit recover kar pati hai ya nahi aur business segments stable hote hain ya grow karte hain.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.